| Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion JHW De Wilt, TLM ten Hagen, G De Boeck, ST Van Tiel, EA De Bruijn, ... British journal of cancer 82 (5), 1000-1003, 2000 | 259 | 2000 |
| TNF-α augments intratumoural concentrations of doxorubicin in TNF-α-based isolated limb perfusion in rat sarcoma models and enhances anti-tumour effects AH van der Veen, JHW de Wilt, AMM Eggermont, ST van Tiel, ... British journal of cancer 82 (4), 973-980, 2000 | 199 | 2000 |
| Tumor necrosis factor α mediates homogeneous distribution of liposomes in murine melanoma that contributes to a better tumor response ALB Seynhaeve, S Hoving, D Schipper, CE Vermeulen, ... Cancer research 67 (19), 9455-9462, 2007 | 187 | 2007 |
| Effects of iron oxide incorporation for long term cell tracking on MSC differentiation in vitro and in vivo E Farrell, P Wielopolski, P Pavljasevic, S van Tiel, H Jahr, J Verhaar, ... Biochemical and biophysical research communications 369 (4), 1076-1081, 2008 | 185 | 2008 |
| Prerequisites for effective isolated limb perfusion using tumour necrosis factor alpha and melphalan in rats JHW De Wilt, ER Manusama, ST Van Tiel, MGA Van Ijken, ... British journal of cancer 80 (1), 161-166, 1999 | 143 | 1999 |
| Low‐dose tumor necrosis factor‐α augments antitumor activity of stealth liposomal doxorubicin (DOXIL®) in soft tissue sarcoma‐bearing rats TLM Ten Hagen, AH Van Der Veen, PTGA Nooijen, ST Van Tiel, ... International journal of cancer 87 (6), 829-837, 2000 | 103 | 2000 |
| Pegylated liposomal tumor necrosis factor‐α results in reduced toxicity and synergistic antitumor activity after systemic administration in combination with liposomal … TLM ten Hagen, ALB Seynhaeve, ST van Tiel, DJ Ruiter, AMM Eggermont International journal of cancer 97 (1), 115-120, 2002 | 88 | 2002 |
| Tumor necrosis factor‐α augmented tumor response in B16BL6 melanoma‐bearing mice treated with stealth liposomal doxorubicin (Doxil®) correlates with altered Doxil® pharmacokinetics P Brouckaert, N Takahashi, ST van Tiel, J Hostens, AMM Eggermont, ... International journal of cancer 109 (3), 442-448, 2004 | 74 | 2004 |
| Nitric oxide synthase inhibition results in synergistic anti-tumour activity with melphalan and tumour necrosis factor alpha-based isolated limb perfusions JHW De Wilt, ER Manusama, B Van Etten, ST Van Tiel, AS Jorna, ... British journal of cancer 83 (9), 1176-1182, 2000 | 71 | 2000 |
| Biodistribution and tumor localization of stealth liposomal tumor necrosis factor‐α in soft tissue sarcoma bearing rats AH van der Veen, AMM Eggermont, ALB Seynhaeve, ST van Tiel, ... International journal of cancer 77 (6), 901-906, 1998 | 65 | 1998 |
| Degree of tumour vascularity correlates with drug accumulation and tumour response upon TNF-α-based isolated hepatic perfusion B van Etten, MR de Vries, MGA van IJken, TE Lans, G Guetens, ... British journal of cancer 88 (2), 314-319, 2003 | 63 | 2003 |
| Labelling of mammalian cells for visualisation by MRI MR Bernsen, AD Moelker, PA Wielopolski, ST van Tiel, GP Krestin European radiology 20, 255-274, 2010 | 57 | 2010 |
| Synergistic antitumor activity of histamine plus melphalan in isolated limb perfusion: preclinical studies F Brunstein, S Hoving, ALB Seynhaeve, ST van Tiel, G Guetens, ... Journal of the National Cancer Institute 96 (21), 1603-1610, 2004 | 49 | 2004 |
| Ferumoxides–protamine sulfate is more effective than ferucarbotran for cell labeling: implications for clinically applicable cell tracking using MRI GM Van Buul, E Farrell, N Kops, ST Van Tiel, PK Bos, H Weinans, ... Contrast media & molecular imaging 4 (5), 230-236, 2009 | 48 | 2009 |
| Facilitating tumor functional assessment by spatially relating 3D tumor histology and in vivo MRI: image registration approach L Alic, JC Haeck, K Bol, S Klein, ST van Tiel, PA Wielepolski, M de Jong, ... PLoS One 6 (8), e22835, 2011 | 45 | 2011 |
| Adenovirus-mediated interleukin 3β gene transfer by isolated limb perfusion inhibits growth of limb sarcoma in rats JHW De Wilt, A Bout, AMM Eggermont, ST Van Tiel, MW De Vries, ... Human gene therapy 12 (5), 489-502, 2001 | 44 | 2001 |
| Early destruction of tumor vasculature in tumor necrosis factor-α-based isolated limb perfusion is responsible for tumor response S Hoving, ALB Seynhaeve, ST van Tiel, G Aan de Wiel-Ambagtsheer, ... Anti-cancer drugs 17 (8), 949-959, 2006 | 43 | 2006 |
| Synergistic Antitumor Response of Interleukin 2 with Melphalan in Isolated Limb Perfusion in Soft Tissue Sarcoma–Bearing Rats S Hoving, F Brunstein, G Aan de Wiel-Ambagtsheer, ST van Tiel, ... Cancer research 65 (10), 4300-4308, 2005 | 42 | 2005 |
| Nanoparticles and clinically applicable cell tracking MR Bernsen, J Guenoun, ST Van Tiel, GP Krestin The British journal of radiology 88 (1054), 20150375, 2015 | 38 | 2015 |
| Isolated limb perfusion with actinomycin D and TNF-alpha results in improved tumour response in soft-tissue sarcoma-bearing rats but is accompanied by severe local toxicity ALB Seynhaeve, JHW De Wilt, ST Van Tiel, AMM Eggermont, ... British journal of cancer 86 (7), 1174-1179, 2002 | 33 | 2002 |
Monique BernsenAssistant professor Molecular ImagingVerified email at erasmusmc.nl
